Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Young Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Ended earlyNCT00949117
What this trial is testing

Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

Who this might be right for
LeukemiaLymphomaMalnutrition+3 more
University of South Florida 9
Not applicableEnded earlyNCT03227185
What this trial is testing

Supporting Episodic Memory With Transcranial Direct Current Stimulation in Healthy Controls and Dementia Patients

Who this might be right for
HealthyMild Cognitive ImpairmentAlzheimer Disease
University of Bern 55
Not applicableUnknownNCT03131089
What this trial is testing

Young Breast Cancer Cohort Study

Who this might be right for
Breast Cancer
Samsung Medical Center 2,000
Testing effectiveness (Phase 2)WithdrawnNCT00389766
What this trial is testing

High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Early research (Phase 1)UnknownNCT00360854
What this trial is testing

Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 48
Not applicableStudy completedNCT06560437
What this trial is testing

Effects of the Manual Therapy on Brain Function in Young Chronic Neck Pain Patients

Who this might be right for
Neck Pain
Wendi Zhang 61
Large-scale testing (Phase 3)Study completedNCT00450450
What this trial is testing

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Childhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous Leukemia+7 more
Children's Oncology Group 27
Testing effectiveness (Phase 2)Looking for participantsNCT02675959
What this trial is testing

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
New York Medical College 40
Testing effectiveness (Phase 2)Study completedNCT00416832
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Christine Mauz-Körholz 648
Post-approval studies (Phase 4)UnknownNCT01746992
What this trial is testing

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Who this might be right for
ALK-negative Anaplastic Large Cell LymphomaPeripherial T Cell Lymphoma,Not Otherwise SpecifiedAngioimmunoblastic T Cell Lymphoma+3 more
Ruijin Hospital 200
Not applicableUnknownNCT03596398
What this trial is testing

Epidemiological Study of Fabry Disease in Taiwan Young Stroke Patients

Who this might be right for
Fabry Disease
Chiayi Christian Hospital 1,000
Not applicableStudy completedNCT05589077
What this trial is testing

Knowledge of Nutritional Concerns in Physically Active Females

Who this might be right for
Nutritional Deficiency
University of North Carolina, Chapel Hill 33
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Not applicableUnknownNCT06216834
What this trial is testing

Quality of Life and Psychosocial Status of Young-onset Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Shandong Provincial Hospital 300
Not applicableStudy completedNCT02800564
What this trial is testing

Change in Child-feeding Knowledge, Attitudes, and Practices With Nutrition Education Mass Media in Ghana

Who this might be right for
Health Education, CommunityDiet, Food, and NutritionMalnutrition+1 more
McGill University 689
Testing effectiveness (Phase 2)Looking for participantsNCT06161974
What this trial is testing

Study of Olutasidenib and Temozolomide in HGG

Who this might be right for
High Grade GliomaAstrocytomaAstrocytoma, Grade III+16 more
Rigel Pharmaceuticals 60
Post-approval studies (Phase 4)UnknownNCT05282420
What this trial is testing

Ranibizumab Versus Aflibercept for CRVO in Young Patients.

Who this might be right for
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
South Valley University 40
Not applicableUnknownNCT03462888
What this trial is testing

Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients

Who this might be right for
Rhabdomyosarcoma
Centre Oscar Lambret 113
Next Page